P Schoenfeld Asset Management LP Makes New Investment in Kenvue Inc. $KVUE

P Schoenfeld Asset Management LP purchased a new position in shares of Kenvue Inc. (NYSE:KVUE) during the second quarter, according to its most recent disclosure with the SEC. The institutional investor purchased 306,200 shares of the company’s stock, valued at approximately $5,851,482. Kenvue accounts for 0.0% of P Schoenfeld Asset Management LP’s holdings, making the stock its 15th biggest position.

Several other hedge funds and other institutional investors also recently modified their holdings of KVUE. Arrowstreet Capital Limited Partnership purchased a new stake in Kenvue during the 2nd quarter valued at about $6,528,000. Jump Financial LLC lifted its position in shares of Kenvue by 210.6% in the second quarter. Jump Financial LLC now owns 54,823 shares of the company’s stock valued at $1,147,000 after acquiring an additional 37,170 shares in the last quarter. AXA S.A. increased its stake in Kenvue by 21.1% during the 2nd quarter. AXA S.A. now owns 48,892 shares of the company’s stock worth $1,023,000 after buying an additional 8,524 shares during the period. NewEdge Advisors LLC boosted its holdings in shares of Kenvue by 219.1% in the second quarter. NewEdge Advisors LLC now owns 97,481 shares of the company’s stock valued at $2,040,000 after acquiring an additional 66,930 shares during the period. Finally, The Manufacturers Life Insurance Company grew its position in Kenvue by 0.6% during the second quarter. The Manufacturers Life Insurance Company now owns 1,873,705 shares of the company’s stock worth $39,217,000 after buying an additional 10,885 shares during the period. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Kenvue Stock Performance

Shares of NYSE KVUE traded up $0.02 during trading hours on Friday, reaching $19.22. The stock had a trading volume of 6,646,003 shares, compared to its average volume of 27,899,273. The company has a current ratio of 1.01, a quick ratio of 0.71 and a debt-to-equity ratio of 0.67. Kenvue Inc. has a fifty-two week low of $14.02 and a fifty-two week high of $20.82. The firm has a market cap of $36.92 billion, a price-to-earnings ratio of 22.09, a PEG ratio of 1.38 and a beta of 0.47. The firm has a 50-day moving average of $19.14 and a 200-day moving average of $18.24.

Kenvue (NYSE:KVUE) last issued its quarterly earnings data on Thursday, August 6th. The company reported $0.31 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.32 by ($0.01). The firm had revenue of $3.96 billion during the quarter, compared to analyst estimates of $3.97 billion. Kenvue had a net margin of 10.76% and a return on equity of 21.22%. The firm’s revenue was up 3.0% compared to the same quarter last year. During the same period last year, the business earned $0.29 EPS. Equities research analysts predict that Kenvue Inc. will post 1.14 earnings per share for the current year.

Kenvue Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, August 26th. Shareholders of record on Wednesday, August 12th were issued a $0.21 dividend. The ex-dividend date of this dividend was Wednesday, August 12th. This represents a $0.84 dividend on an annualized basis and a yield of 4.4%. This is a positive change from Kenvue’s previous quarterly dividend of $0.21. Kenvue’s payout ratio is currently 96.55%.

Wall Street Analyst Weigh In

Several analysts recently issued reports on the company. UBS Group cut their price target on Kenvue from $20.00 to $19.00 and set a “neutral” rating on the stock in a report on Tuesday, August 11th. Zacks Research lowered shares of Kenvue from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, July 7th. Wall Street Zen lowered Kenvue from a “buy” rating to a “hold” rating in a research report on Saturday, August 8th. Barclays boosted their price target on shares of Kenvue from $18.00 to $19.00 and gave the stock an “equal weight” rating in a report on Tuesday, July 21st. Finally, Weiss Ratings upgraded shares of Kenvue from a “hold (c-)” rating to a “hold (c)” rating in a research report on Monday, June 15th. Three equities research analysts have rated the stock with a Buy rating and twelve have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $19.27.

Kenvue Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.